Patents
Patents for C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
04/2003
04/16/2003CN1411455A Method for producing liquid crystals with CF20 bond
04/10/2003US20030069433 Producing liquid crystals with cf2o bond
04/09/2003EP1300398A1 Propane-1,3-dione derivatives
04/09/2003EP0799220B1 Polymerisable monomers and polymers
04/08/2003US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors
04/03/2003WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
04/02/2003EP1296943A1 Amino acid derivatives and their use as medicines
04/02/2003EP0730449B1 Novel palladium complexes and methods for using same in the treatment of tumors and psoriasis
04/01/2003US6541473 Resorcinol derivatives
03/2003
03/27/2003US20030059865 Oligo(ethylene glycoll)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/27/2003US20030059710 Photosensitive patterns; semiconductor
03/26/2003EP1294353A1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/13/2003US20030050332 Modifications of the trometamol salt of R-thioctic acid as well as a process for their production
03/12/2003EP1289522A2 Medicaments for treating dementia
03/12/2003EP1289521A2 Combination of lipoic acid and c 1 donors for the treatment of disorders of the central nervous system
03/06/2003US20030044402 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/06/2003DE10152113C1 Alkyl (R)- or (S)-8-chloro-6-hydroxy-octanoate preparation, for use as intermediate for (R)- or (S)-alpha-lipoic acid, by enzymatic reduction of 6-oxo compound using alcohol dehydrogenases or carbonyl reductase
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/04/2003US6528601 Polymerizable sulfur-containing (meth) acrylate, polymerizable composition and optical lens
02/2003
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/19/2003EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
02/13/2003WO2003011852A1 Novel modifications of the trometamol salt of r-thioctic acid and method for producing the same
02/11/2003US6518300 Antiplipemic agent, anticholesterol agents
01/2003
01/30/2003WO2003008404A2 Sulfonium salts as phtoinitiators for radiation curable systems
01/30/2003WO2002044163A3 Method for producing lipoic acid and dihydrolipoic acid
01/30/2003WO2002010151A2 Method for producing lipoic acid and dihydrolipoic acid
01/30/2003CA2417842A1 Method for producing lipoic acid and dihydrolipoic acid
01/29/2003EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
01/29/2003EP1202983B1 Method for the production of a solvent-free alpha- liponic acid
01/24/2003WO2002010113A1 Method for producing enantiomer-free 6,8 dihydroxy octanoic acid esters by means of asymmetric, catalytic hydrogenation
01/24/2003CA2417269A1 Method for producing enantiomer-free 6,8 dihydroxy octanoic acid esters by means of asymmetric, catalytic hydrogenation
01/23/2003WO2003005960A2 Novel bicyclic and tricyclic cannabinoids
01/16/2003US20030013894 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane
01/16/2003US20030013847 Pyruvate derivatives
01/16/2003US20030013846 Cytoprotective agents
01/16/2003US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
01/16/2003US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
01/09/2003WO2003002557A1 Novel compounds for use as photoinitiators
12/2002
12/31/2002US6500958 Carboxylic acid derivatives and process for producing the same
12/31/2002US6500503 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
12/27/2002WO2002103340A2 Method and device for the detection of trace amounts of a substance,using a piezoelectric crystal element
12/27/2002WO2002036585A3 Process for the preparation of ligands for olefin polymerization catalysts
12/25/2002CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/18/2002EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002CN1096458C 2-hetaroylcyclohexane-1,3-diones
12/17/2002US6495643 Ring opening polymerization of such as 6-methylene-1,4-dithiepane optionally with methyl methacrylate; minimizing shrinkage; high molecular weight; such as amide, ester or carbonate backbone groups; adhesives, composites, lenses
12/04/2002CN1383423A 6-fluorobicyclo [3.1.0] hexame derivatives
12/03/2002US6489430 A polyisocyanate compound containing 1-4-dithian ring, useful for making polyurethane optical lens, prism, optical fiber, substrate for recording medium and filter
11/2002
11/28/2002US20020177622 Neuroprotectants; enhancing cognition
11/27/2002EP1259503A1 Producing liquid crystals with cf2o bond
11/21/2002WO2002092591A1 Acrylic esters and use thereof
11/21/2002WO2002091993A2 Estrogen receptor modulators
11/21/2002US20020173631 4-((5,5-dimethyl-5,6,7,8-tetrahydro-8-hydroxynaphthalen-2 -yl)carbonyloxy)benzoic acid, benzyl ester for example; receptor subtype selectivity for side effect reduction
11/21/2002CA2445922A1 Estrogen receptor modulators
11/20/2002EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/19/2002US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/14/2002WO2002090314A1 Pyruvate derivatives
11/14/2002WO2002089578A1 Microencapsulated antibacterial
11/14/2002WO2002010151A3 Method for producing lipoic acid and dihydrolipoic acid
11/12/2002US6479674 Carboxylic acid derivatives and process for producing same
11/12/2002CA2068083C Anti-bacterial compound
11/07/2002US20020165226 Estrogen receptor modulators
10/2002
10/29/2002US6472545 For therapy of diabetes, obesity
10/29/2002US6472488 (Thio) (meth) acrylate monomers, intermediate compounds for the synthesis of these monomers, polymerizable compositions and polymers obtained, and their optical and ophthalmic uses
10/24/2002US20020156299 Novel carboxylic acid derivatives and process for producing the same
10/22/2002CA2073084C The use of sulphur-containing carboxylic acids to combat physiologically-induced excitatory disorders and diseases related thereto as well as allergic diseases and also the preparation of corresponding medicaments
10/17/2002WO2002081447A1 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
10/17/2002US20020151578 Formulation based on lipoic acid, process for its production and the use of this formulation for oral administration of lipoic acid
10/16/2002EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/15/2002US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/10/2002US20020147234 Nitrate esters and methods of making same
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/08/2002US6462202 Dissolving the salt thereof in water and adjusting to an alkaline ph, filtration to remove solids, acidification to precipitate the alpha-lipoic acid
10/03/2002WO2002064583A3 Bis(alkylthio)carbenium salts
10/03/2002US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/02/2002EP1151021A4 Initiator compositions and methods for their synthesis and use
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002US6458908 A process for preparing a sulfur-containing unsaturated carboxylate compound as claimed in claim 1 comprising reacting a sulfur-containing derivative for optical polymers
10/01/2002US6458785 Aids therapy
09/2002
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002CA2439539A1 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/25/2002EP1242851A1 Use of a composition in stereolithography
09/25/2002CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
09/18/2002EP1100793B1 Crystal modification of lipoic acid
09/18/2002EP0823889B1 1,3-propane diol derivatives as bioactive compounds
09/05/2002DE10207958A1 Solid formulation containing lipoic acid in molecularly dispersed form, useful e.g. as antiinflammatory, or in cosmetics or feed supplements, is storage stable
09/04/2002EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
09/04/2002EP0746551B1 Optically pure 4-aryl-2-hydroxytetronic acids
08/2002
08/29/2002US20020120168 Difluoromethyl ether derivative and process for producing the same
08/27/2002US6441024 Crystal modification of lipoic acid
08/27/2002US6440899 Cyclohexenonedioxothiochromanoyl derivatives
08/22/2002WO2002064583A2 Bis(alkylthio)carbenium salts
08/22/2002WO2002032377A3 Estrogen receptor modulators
08/22/2002US20020115868 Novel process for making 5-substituted pyrazoles
08/22/2002DE10106577A1 Bis(alkylthio)carbeniumsalze Bis (alkylthio) carbenium
08/15/2002US20020111385 Synergistic mixtures
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 34